loxiglumide has been researched along with glutamine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biliotti, D; Bontempo, I; Corazziari, E; De Medici, A; Pallotta, N; Ricci, R; Torsoli, A | 1 |
| Beglinger, C; Gyr, K; Hildebrand, P; Jansen, JB; Lamers, CB; Rovati, LC; Setnikar, I; Stalder, GA; Zuercher, M | 1 |
| Bonato, C; De Fazio, C; Festorazzi, S; Malesci, A; Rovati, L; Setnikar, I; Tacconi, M; Valentini, A | 1 |
| Baba, H; Fujimura, M; Toda, N | 1 |
| Fujii, M; Itoh, H; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 1 |
| Douglas, BR; Jansen, JB; Jebbink, MC; Lamers, CB | 1 |
| Jansen, JB; Jebbink, MC; Lamers, CB; Masclee, AA | 1 |
| Bastié, MJ; Pradayrol, L; Scemama, JL; Seva, C; Vaysse, N | 1 |
| Gabryelewicz, A; Konturek, SJ; Kulesza, E | 1 |
| Fanali, S; Farina, A; Nardi, A; Quaglia, MG | 1 |
| Baba, S; Fujii, M; Fujisawa, T; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S | 2 |
| Adler, G; Beglinger, C; Dill, S; Meyer, B; Werth, B | 1 |
| Chisté, R; Giacovelli, G; Rovati, LC; Setnikar, I | 1 |
| Fujii, K; Kishimoto, M; Miyoshi, A | 1 |
| Adler, G; Arnold, R; Göke, B; Koop, I; Reinshagen, M; Rovati, LC; Schafmayer, A | 1 |
| Bogdal, J; Konturek, JW; Konturek, SJ; Kurek, A; Oleksy, J; Rovati, L | 1 |
| Chisté, R; Makovec, F; Rovati, LC; Setnikar, I; Warrington, SJ | 1 |
| Bani, M; Cereda, R; Chisté, R; Makovec, F; Pacini, MA; Revel, L; Setnikar, I | 2 |
| Beglinger, C; Gyr, K; Hildebrand, P; Köhler, E; Setnikar, I | 1 |
| Bani, M; Cereda, R; Chisté, R; Makovec, F; Pacini, MA; Revel, L; Rovati, LA; Rovati, LC; Setnikar, I | 1 |
2 trial(s) available for loxiglumide and glutamine
| Article | Year |
|---|---|
Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
Topics: Administration, Oral; Adult; Cholecystokinin; Double-Blind Method; Female; Food; Gallbladder; Gastric Emptying; Glutamine; Humans; Male; Muscle Contraction; Proglumide; Random Allocation | 1990 |
Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
Topics: Adult; Cholecystokinin; Female; Glutamine; Half-Life; Humans; Male; Proglumide | 1990 |
20 other study(ies) available for loxiglumide and glutamine
| Article | Year |
|---|---|
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Topics: Adult; Bile Acids and Salts; Cholecystokinin; Food; Glutamine; Humans; Intestines; Male; Pancreas; Pancreatic Polypeptide; Proglumide; Receptors, Cholecystokinin | 1990 |
Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
Topics: Adult; Ceruletide; Cholecystokinin; Dose-Response Relationship, Drug; Drug Interactions; Feeding Behavior; Gallbladder; Glutamine; Humans; Male; Muscle Contraction; Proglumide; Reference Values; Time Factors | 1990 |
Mechanism of inhibitory action of peptide YY on cholecystokinin-induced contractions of isolated dog ileum.
Topics: Animals; Cholecystokinin; Dogs; Female; Gallbladder; Glutamine; Ileum; Isometric Contraction; Male; Muscle Contraction; Peptide YY; Peptides; Proglumide; Sincalide | 1990 |
Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Topics: Acute Disease; Animals; Ceruletide; Cholecystokinin; Disease Models, Animal; Glutamine; Male; Pancreatitis; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Taurocholic Acid | 1990 |
Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Topics: Adult; Bombesin; Cholecystokinin; Female; Food; Glutamine; Humans; Male; Proglumide; Receptors, Cholecystokinin | 1990 |
Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
Topics: Animals; DNA, Neoplasm; Gastrins; Glutamine; Ornithine Decarboxylase; Pancreatic Neoplasms; Proglumide; Rats; Receptors, Cholecystokinin; Thymidine; Tumor Cells, Cultured | 1990 |
Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Topics: Adult; Atropine; Bicarbonates; Cholecystokinin; Duodenum; Eating; Food, Formulated; Glutamine; Humans; Infusions, Intravenous; Pancreas; Proglumide; Receptors, Cholecystokinin; Secretin; Secretory Rate | 1990 |
Determination of loxiglumide in pharmaceutical preparations by using capillary zone electrophoresis.
Topics: Electrophoresis; Glutamine; Proglumide; Tablets | 1990 |
Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Topics: Amylases; Animals; Binding, Competitive; Cholecystokinin; Dose-Response Relationship, Drug; Glutamine; Pancreas; Proglumide; Rats; Receptors, Cholecystokinin; Sincalide | 1989 |
[Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Topics: Amylases; Animals; Cholecystokinin; Glutamine; In Vitro Techniques; Male; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Sincalide | 1989 |
Treatment of biliary colic with loxiglumide.
Topics: Biliary Tract Diseases; Cholecystokinin; Colic; Female; Glutamine; Humans; Male; Proglumide; Time Factors | 1989 |
Pharmacokinetics and tolerance of repeated oral doses of loxiglumide.
Topics: Adult; Biotransformation; Cholecystokinin; Female; Glutamine; Humans; Male; Patient Compliance; Proglumide | 1989 |
[Effect of CCK on the large intestine].
Topics: Animals; Cholecystokinin; Gastrointestinal Motility; Glutamine; Intestine, Large; Male; Muscle Contraction; Muscle, Smooth; Proglumide; Rats; Rats, Inbred Strains | 1989 |
Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
Topics: Adult; Atropine; Cholecystokinin; Dose-Response Relationship, Drug; Esters; Feedback; Gabexate; Glutamine; Guanidines; Humans; Male; Pancreas; Peptide Hydrolases; Proglumide; Protease Inhibitors; Pulse; Reference Values | 1989 |
CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
Topics: Adolescent; Adult; Cholecystokinin; Food; Gallbladder; Glutamine; Humans; Male; Muscle Contraction; Proglumide; Receptors, Cholecystokinin; Sincalide | 1989 |
Pharmacokinetics of loxiglumide after single intravenous or oral doses in man.
Topics: Administration, Oral; Adult; Cholecystokinin; Chromatography, High Pressure Liquid; Glutamine; Humans; Infusions, Intravenous; Injections, Intravenous; Proglumide | 1988 |
Anticholecystokinin activities of loxiglumide.
Topics: Anesthesia; Animals; Ceruletide; Cholecystokinin; Dogs; Female; Gallbladder; Gastrointestinal Motility; Glutamine; Guinea Pigs; In Vitro Techniques; Male; Mice; Pancreas; Proglumide; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1987 |
Loxiglumide protects against experimental pancreatitis.
Topics: Animals; Ceruletide; Diet; Female; Glutamine; Male; Mice; Pancreatitis; Proglumide; Rats; Rats, Inbred Strains; Taurocholic Acid | 1987 |
Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
Topics: Animals; Cholecystokinin; Dogs; Dose-Response Relationship, Drug; Gastric Acid; Glutamine; Infusions, Intravenous; Pancreatic Juice; Pancreatic Polypeptide; Pentagastrin; Proglumide; Sincalide | 1987 |
Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
Topics: Animals; Cerebral Cortex; Cholecystokinin; Female; Gallbladder; Glutamine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Pancreas; Proglumide; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Species Specificity | 1987 |